- Home
- CNF vs SBFM Comparison
CNF vs SBFM Comparison
Compare CNF & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNF
- SBFM
- Stock Information
- Founded
- CNF 1999
- SBFM 2006
- Country
- CNF China
- SBFM United States
- Employees
- CNF N/A
- SBFM N/A
- Industry
- CNF Finance: Consumer Services
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- CNF Finance
- SBFM Health Care
- Exchange
- CNF Nasdaq
- SBFM Nasdaq
- Market Cap
- CNF N/A
- SBFM 4.9M
- IPO Year
- CNF 2018
- SBFM N/A
- Fundamental
- Price
- CNF $0.67
- SBFM $1.44
- Analyst Decision
- CNF
- SBFM Strong Buy
- Analyst Count
- CNF 0
- SBFM 1
- Target Price
- CNF N/A
- SBFM $15.00
- AVG Volume (30 Days)
- CNF 33.7K
- SBFM 4.4M
- Earning Date
- CNF 05-06-2025
- SBFM 05-19-2025
- Dividend Yield
- CNF N/A
- SBFM N/A
- EPS Growth
- CNF N/A
- SBFM N/A
- EPS
- CNF 0.24
- SBFM N/A
- Revenue
- CNF $109,788,152.00
- SBFM $34,874,283.00
- Revenue This Year
- CNF $130.65
- SBFM $192.48
- Revenue Next Year
- CNF $13.09
- SBFM N/A
- P/E Ratio
- CNF $2.75
- SBFM N/A
- Revenue Growth
- CNF 12.99
- SBFM 44.75
- 52 Week Low
- CNF $0.60
- SBFM $1.17
- 52 Week High
- CNF $2.84
- SBFM $33.60
- Technical
- Relative Strength Index (RSI)
- CNF 34.58
- SBFM 40.53
- Support Level
- CNF $0.71
- SBFM $1.17
- Resistance Level
- CNF $0.77
- SBFM $1.59
- Average True Range (ATR)
- CNF 0.06
- SBFM 0.17
- MACD
- CNF 0.01
- SBFM 0.04
- Stochastic Oscillator
- CNF 10.91
- SBFM 56.34
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.